5.74% 0.475

Immunitybio Inc (IBRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IBRX? Forum Prognose

Finanzdaten der Immunitybio Inc-Aktie (IBRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	19.41% 38.28	32.06	26.43	16.52	6.106
Cost Of Revenue	115.82% 0.382	0.177	0.136	0.058	-
Gross Profit	18.88% 37.90	31.88	26.29	16.46	-
Operating Expenses	17.22% 102.59	87.51	97.57	80.89	86.36
Interest Income/Expense	2.71% 14.84	15.26	15.47	15.31	29.32
Benefits Costs and Expenses	1.01% 100.38	99.37	118.73	146.42	91.86
Costs And Expenses	17.42% 102.97	87.69	97.71	80.95	91.86
Operating Income/Loss	16.27% -64.68	-55.63	-71.28	-64.43	-80.25
Nonoperating Income/Loss	122.18% 2.59	-11.68	-21.02	-65.47	-5.499
Income/Loss From Continuing Operations Before Tax	7.75% -62.09	-67.31	-92.31	-129.90	-85.75
Income Tax Expense/Benefit	285.71% -0.135	-0.035	0.269	-0.234	-
Income/Loss From Continuing Operations After Tax	7.90% -61.96	-67.27	-92.57	-129.67	-85.75
Net Income/Loss	7.90% -61.96	-67.27	-92.57	-129.67	-85.75
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	33.33% -0.014	-0.021	-0.019	-0.02	-0.023
Basic Average Shares	97.51% 23.53	946.60	888.22	853.16	695.89
Diluted Average Shares	97.51% 23.53	946.60	888.22	853.16	697.96
Basic Earnings Per Share	14.29% -0.06	-0.07	-0.10	-0.15	-0.12
Diluted Earnings Per Share	14.29% -0.06	-0.07	-0.10	-0.15	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%